Steiner, T. M., Le, B., Harrop, S., ZuairiaTabassum, F., Tobar, L., Zhu, R., Macdonald, S., Lau, L., Sutton, V., Trapani, J., Thio, N., Minson, A., Dickinson, M., Neeson, P. (2025). DLBCL tumor microenvironment archetype and CD4+ T cell conversion to cytotoxic cells are required for response to glofitamab. Blood. https://doi.org/10.1182/blood-2025-557